[Fertility preservation and treatment outcomes in female patients with chronic-phase chronic myeloid leukemia: a single-institution experience].

View at publisher Summarise with VIRAT
Authors: Itaru Sato, Yuki Nakajima, Kosuke Takayama, Yuto Hibino, Yoshimi Ishii, Takuya Miyazaki, Shin Fujisawa, Hideaki Nakajima
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Few reports describe the use of assisted reproductive technology (ART) for fertility preservation and conception in patients with chronic phase chronic myeloid leukemia (CML-CP). We conducted an observational study on fertility preservation and pregnancy outcomes in 18 female CML-CP patients aged 15 to 39 years treated at our hospital from December 2001 to May 2024. The median age at diagnosis was 24.5 years. All of the 10 patients diagnosed after 2013 received information about fertility preservation before treatment initiation. Three of the 7 eligible patients underwent fertility preservation. All patients who underwent fertility preservation started tyrosine kinase inhibitor (TKI) therapy within one month of diagnosis. One patient underwent fertility preservation while in treatment-free remission (TFR) after TKI initiation. Three patients desired pregnancy and achieved 3 live births via natural conception or ART under TFR. No patient lost major molecular response while trying to conceive or during pregnancy and childbirth. Planned pregnancies under TFR allow for both disease control and successful conception and childbirth, with ART being particularly effective.

Fields of Study & Subjects

Reproductive Biology and Fertility Chronic Myeloid Leukemia Treatments Reproductive Health and Technologies

Publication details

Journal / source
PubMed
Volume
67
Issue
3
Pages
192–197
Publication date
1 January 2026
Language
JA